Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 8, 2015, Pages 9404-9409

  Zhang, Shi Yan ^a   Lin, Min ^a   Zhang, Hui Bing ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Carbohydrate antigen 19 9; Carcinoembryonic antigen; Colorectal carcinoma; Sensitivity; Specificity

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; BLOOD; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RECTAL DISEASES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL DISEASES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 85012991897     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chan CC, Fan CW, Kuo YB, Chen YH, Chang PY, Chen KT, Hung RP, Chan EC. Multiple serological biomarkers for colorectal cancer detection. Int J Cancer 2010; 126: 1683-90.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 CA Cancer J Clin 2015; 65: 5-29.
3. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized Colorectal Cancer Screening in Integrated Health Care Systems. Epidemiologic Reviews 2011; 33: 101-10.
4. Al-Shuneigat JM, Mahgoub SS, Huq F. Colo-rectal carcinoma: nucleosomes, carcinoembr-yonic antigen and ca 19-9 as apoptotic markers; a comparative study. J Biomed Sci 2011; 18: 50.
5. Swiderska M, Choromanska B, Dabrowska E, Konarzewska-Duchnowska E, Choromanska K, Szczurko G, Mysliwiec P, Dadan J, Ladny JR, Zwierz K. The diagnostics of colorectal cancer. Contemp Oncol (Pozn) 2014; 18: 1-6.
6. Sajid KM, Parveen R, Durr-e-Sabih, Chaouachi K, Naeem A, Mahmood R, Shamim R. Car-cinoembryonic antigen (CEA) levels in hookah smokers, cigarette smokers and non-smokers. J Pak Med Assoc 2007; 57: 595-9.
7. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski VR Jr. Radioimmu-nometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983; 29: 549-52.
8. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58: 130-60.
9. Lee JH. Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer. Nucl Med Mol Imaging 2013; 47: 181-7.
10. Zheng CX, Zhan WH, Zhao JZ, Zheng D, Wang DP, He YL, Zheng ZQ. The prognostic value of preoperative serum levels. World J Gastroen-terol 2001; 7: 431-4.
11. Stiksma J, Grootendorst DC, van der Linden PW. CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer. Clin Colorectal Cancer 2014; 13: 239-44.